ARAV Stock, Aravive Inc. Information
Stock Information
Get ARAV Alerts
News, Short Squeeze, Breakout and More Instantly...
About Aravive Inc.
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. Aravive's lead candidate is batiraxcept, which is is an ultrahigh-affinity, decoy protein that targets the GAS6-AXL signaling pathway.